Heart Research - Latest News and Updates

The field of medical technology has seen remarkable advancements over the years, and one of the most promising frontiers is the application of laser technology in the treatment of heart conditions. This innovative approach is ushering in a revolution in cardiac care , offering new and improved methods for diagnosis, treatment, and even prevention. Here, we explore the potential of laser technology for the heart and its transformative impact on the world of cardiology . Precise Diagnostics Laser technology is revolutionizing the diagnostic process for heart-related issues. Traditional diagnostic methods often involve invasive procedures or radiation exposure, both of which carry risks and discomfort for patients. Laser-based diagnostic tools, on the other hand, offer non-invasive, precise, and safe options. One such innovation is laser Doppler vibrometry , which can measure the minute vibrations in the heart, providing valuable insights into cardiac health. This non-contact technique

Cardiovascular-Kidney-Metabolic (CKM) syndrome is a cluster of conditions that increase the risk of heart disease, stroke, kidney failure, and other serious health problems. CKM syndrome is linked to obesity and diabetes, but it can also develop in people who are not obese or diabetic. CKM syndrome is a serious condition, but it is important to remember that it is preventable and treatable. By making lifestyle changes and taking medications as prescribed, people with CKM syndrome can reduce their risk of complications and live long, healthy lives. Symptoms of CKM syndrome: The symptoms of CKM syndrome can vary depending on the specific conditions that a person has. However, some common symptoms include: High blood pressure, High cholesterol, High blood sugar, Obesity, Abdominal obesity, Insulin resistance, Kidney damage, Heart disease , Stroke, Peripheral artery disease, Erectile, dysfunction, Sleep apnea. Risk factors for CKM syndrome: The following factors put people at increased r

Heart failure is a chronic condition that affects the heart's ability to pump blood effectively. It is a leading cause of death and hospitalization in adults, and it is estimated that over 6 million Americans have heart failure. There are two main types of heart failure: heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) . HFrEF is the more common type of heart failure, and it is characterized by a weakened heart muscle that cannot pump blood as efficiently as it should. HFpEF is a more complex type of heart failure, and it is characterized by a normal ejection fraction, which is the percentage of blood that is pumped out of the heart with each beat. Obesity is a major risk factor for both HFrEF and HFpEF. In fact, obesity is the most common underlying cause of HFpEF. Losing weight can help to improve heart function and reduce the risk of heart failure in obese patients. A new weight loss drug called semaglutide (brand

World Heart Day is celebrated annually on September 29th, aiming to raise awareness about cardiovascular diseases (CVD) and promote heart-healthy habits globally. This initiative was established by the World Heart Federation (WHF), a non-governmental organization dedicated to preventing and controlling heart disease worldwide. Understanding the history and significance of World Heart Day is crucial in the ongoing effort to combat cardiovascular diseases, which remain a leading cause of mortality across the globe. History: World Heart Day was first observed in the year 2000, making 2023 the 24th anniversary of this global health initiative. The World Heart Federation , founded in 1978, played a pivotal role in initiating this campaign. The idea was to create a platform that could unite people, communities, and organizations from all walks of life to focus on the prevention and management of cardiovascular diseases. The foundation of World Heart Day lies in the recognition of the esca

Work-related stress is a significant concern in modern society, with far-reaching implications for both individual health and workplace productivity. One of the most concerning consequences of chronic work stress is its association with heart disease , a leading cause of mortality worldwide. Understanding the intricate link between work stress and heart disease is essential for both employees and employers to mitigate its detrimental effects. The connection between work stress and heart disease becomes even more pronounced when considering the role of inflammation. Chronic stress can provoke inflammation throughout the body, which has been linked to the development of atherosclerosis. Atherosclerosis occurs when fatty deposits accumulate in the arteries, causing them to narrow and harden. This condition restricts blood flow and can lead to heart attacks and strokes , making it a significant risk factor for heart disease. Here are some of the key factors contributing to the connecti

Near-death experiences (NDEs) are profoundly mysterious and often life-altering events reported by some individuals who have faced life-threatening situations, including cardiac arrest . These experiences have fascinated scientists, theologians, and the general public for decades due to their enigmatic nature and their potential implications for our understanding of consciousness and the afterlife. One of the most striking aspects of NDEs during cardiac arrest is the feeling of detachment from the physical body. Many individuals who have gone through cardiac arrest and reported NDEs describe a sensation of floating above their own bodies or observing medical procedures from an elevated perspective. This out-of-body experience challenges our conventional understanding of consciousness, as it suggests that awareness can exist independently of the physical body. Another common element of NDEs is the perception of moving through a tunnel or towards a bright , radiant light. This light i

Left Ventricular Function (LVEF) is a measure of how well the heart pumps blood. It is an important indicator of heart health and is used to diagnose and manage heart disease . LVEF is typically estimated by a sonographer, who uses an ultrasound machine to create images of the heart. However, sonographers can sometimes make errors in their estimates, which can lead to misdiagnosis or delayed treatment. A new AI algorithm called EchoNet has shown promise for more accurate and efficient LVEF estimation. EchoNet was trained on a large dataset of echocardiograms and can identify subtle changes in heart function that would be difficult to spot by eye. In a study published in the journal Nature, EchoNet was found to be more accurate than sonographers in estimating LVEF, and it was also able to do so more efficiently. The study involved 1,000 patients who were undergoing echocardiography . The echocardiograms were analyzed by both sonographers and EchoNet. EchoNet was able to estimate LVE